15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for MMS yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $56.35 current
Highest Target—
Average Target—
Lowest Target—
MMS analyst recommendation trends
86420
Sep
Oct
Nov
Dec
Strong BuyBuyHoldSellStrong Sell
RATING
SEP
OCT
NOV
DEC
Strong Buy
0
0
0
0
Buy
1
1
1
1
Hold
0
0
0
0
Sell
0
0
0
0
Strong Sell
0
0
0
0
Total
1
1
1
1
As of Dec, 1 of 1 firms rate MMS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MMS EPS & revenue forecast
EPS · NEXT QUARTER
$1.92
Range $1.92 – $1.92 · 1 analysts · +4% YoY
Next period, 1 analysts expect Maximus Inc to earn $1.92 a share (range $1.92 – $1.92), versus $1.85 a year earlier. Full-year consensus is $8.01, growing to $8.36 the year after.
REVENUE · NEXT QUARTER
$1.4B
Range $1.4B – $1.4B · 1 analysts · +5% YoY
Revenue is expected to reach $1.4B (range $1.4B – $1.4B), +4.8% year-over-year. Full-year consensus is $5.2B, rising to $5.4B next year.
Top analysts covering Maximus Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MMS.
#1
Brian Gesuale
Raymond James · Rank #303
Buy
$90.00+59.7% to target
Overall win rate
38%
+ Follow
MMS stock forecast FAQ
Who is the most accurate analyst covering MMS?+
Among analysts who currently cover MMS, Brian Gesuale of Raymond James has the strongest overall Quantellect track record (Rank #303). Their current call is Buy with a $90.00 target.
What is Maximus Inc's projected EPS for next quarter?+
The consensus estimate is $1.92 per share (range $1.92 – $1.92) across 1 analysts. Full-year EPS is projected at $8.01, rising to $8.36 the following year.
How much revenue is Maximus Inc expected to report next quarter?+
Consensus revenue is $1.4B (range $1.4B – $1.4B). Full-year revenue is projected at $5.2B, growing to $5.4B next year.
Have analysts been upgrading or downgrading MMS lately?+
As of Dec, 1 of 1 firms rate MMS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MMS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
